2019
DOI: 10.1007/s12185-019-02755-2
|View full text |Cite
|
Sign up to set email alerts
|

Successful granulocyte apheresis using medium molecular weight hydroxyethyl starch

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
6
0

Year Published

2021
2021
2025
2025

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(8 citation statements)
references
References 27 publications
2
6
0
Order By: Relevance
“…The number of granulocytes collected in our study was comparable to those collected in studies in which GC was carried out without HES but lower than those seen in previously reported studies involving the use of HES [21,28,33,34]. Recently, HES of medium molecular weight was reported to be a safe and effective alternative to HES for granulocyte apheresis [35]. Alternative erythrocyte sedimentation agents may be an option in countries where HES is unavailable.…”
Section: Discussionsupporting
confidence: 65%
“…The number of granulocytes collected in our study was comparable to those collected in studies in which GC was carried out without HES but lower than those seen in previously reported studies involving the use of HES [21,28,33,34]. Recently, HES of medium molecular weight was reported to be a safe and effective alternative to HES for granulocyte apheresis [35]. Alternative erythrocyte sedimentation agents may be an option in countries where HES is unavailable.…”
Section: Discussionsupporting
confidence: 65%
“…For donor safety, it might be crucial to minimize the processing time and PBV. In contrast, the granulocyte CE in the m0.8 group was similar to the hHES group and was not inferior to other reports with HES130/0.4 12,13 . Although there was no significant difference, the CE tended to be highest with the m0.44 method, with the slowest flow rates of 40 mL/min among m0.46, m0.44, and m0.37.…”
Section: Discussionsupporting
confidence: 46%
“…The development of hematological abnormalities and diffused tissue storage has been reported in patients with renal failure who had excessive HES exposure 11 . Recent reports demonstrated that sufficient granulocytes could be harvested via apheresis using a medium molecular weight HES (mHES) (HES130/0.4: Voluven®; Otsuka Pharmaceutical Factory, Inc., Tokushima, Japan) 12–14 . HES130/0.4 is a third‐generation HES characterized by an average molecular weight of 130,000 Dalton and a molar substitution of 0.4.…”
Section: Introductionmentioning
confidence: 99%
“…Several other studies have explored other RBC‐sedimenting agents apart from high‐molecular‐weight HES, which has been the standard and was used in the current study. Recently, Nannya et al reported the efficacy of 130 kDa HES, which is categorised as low‐ to medium‐molecular‐weight HES, in granulocyte collections from seven donors 23 . They performed granulocyte apheresis for two consecutive days using Spectra Optia; the CE2 on days 1 and 2 of apheresis was reported to be 14.5% ± 2.8% and 13.7% ± 2.8%, respectively.…”
Section: Discussionmentioning
confidence: 99%